Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
出版年份 2014 全文链接
标题
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 40, Issue 11-12, Pages 1292-1301
出版商
Wiley
发表日期
2014-10-15
DOI
10.1111/apt.12979
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fut2genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis
- (2014) C. Rupp et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
- (2014) Marcial Sebode et al. JOURNAL OF HEPATOLOGY
- Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
- (2013) J. H. Tabibian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis
- (2013) Lina Lindström et al. Clinical Gastroenterology and Hepatology
- Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
- (2013) John E. Eaton et al. GASTROENTEROLOGY
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
- (2013) Andreas Wannhoff et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis
- (2013) Gideon M Hirschfield et al. LANCET
- Approach to a Patient with Elevated Serum Alkaline Phosphatase
- (2012) Asma Siddique et al. Clinics in Liver Disease
- Genome-wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci atGPR35andTCF4
- (2012) David Ellinghaus et al. HEPATOLOGY
- Improvement of serum alkaline phosphatase to
- (2012) Said Al Mamari et al. JOURNAL OF HEPATOLOGY
- Non-IBD immunological diseases are a risk factor for reduced survival in PSC
- (2012) Christian Rupp et al. LIVER INTERNATIONAL
- High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
- (2011) M. H. Imam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
- (2011) John E Eaton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis
- (2011) Peter P. Stanich et al. DIGESTIVE AND LIVER DISEASE
- Cancer surveillance in patients with primary sclerosing cholangitis
- (2011) Nataliya Razumilava et al. HEPATOLOGY
- Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
- (2010) Teru Kumagi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment
- (2010) Daniel N. Gotthardt et al. GASTROINTESTINAL ENDOSCOPY
- Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
- (2010) Espen Melum et al. NATURE GENETICS
- Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- (2009) Tom H. Karlsen et al. GASTROENTEROLOGY
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
- (2009) Gerda Rudolph et al. JOURNAL OF HEPATOLOGY
- The immunobiology of primary sclerosing cholangitis
- (2009) Jonathan H. Aron et al. Seminars in Immunopathology
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
- High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
- (2008) Susan N. Cullen et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started